CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity & Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With Merck & Company, Inc. Measles-Mumps-Rubella Vaccine (M-M-RII) & Merck & Co Varicella Vaccine (VARIVAX™) to Children 15 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00197015
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:51.177836+00:00
Published At: 2010-04-01T00:00:00+00:00
Record Updated At: 2018-07-31
Results Posted At: 2010-04-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis A"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-31"
protocolSection.identificationModule.nctId: "NCT00197015"
protocolSection.identificationModule.officialTitle: "Immunogenicity \u0026 Safety of GSK Biologicals\u0027 Inactivated Hepatitis A Vaccine (Havrix\u2122) Co-administered With Merck \u0026 Company, Inc. Measles-Mumps-Rubella Vaccine (M-M-RII) \u0026 Merck \u0026 Co Varicella Vaccine (VARIVAX\u2122) to Children 15 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-04-01"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.